疑似子痫前期6小时与24小时尿蛋白采集管理妊娠的随机双盲对照预试验
该随机双盲预试验纳入115例因疑似子痫前期住院的孕妇,1:1分为6小时和24小时尿蛋白采集组,主要结局为不良 maternal 结局复合指标。结果显示两组复合不良 maternal 结局率分别为15.6%和12.0%(P=.59),新生儿结局无显著差异,提示6小时尿蛋白采集管理可行且结局相似。
要点
- 6小时与24小时尿蛋白采集组不良 maternal 结局复合率分别为15.6%和12.0%(P=.59),无显著差异。
- 两组新生儿不良结局、剖宫产、引产、分娩孕周、倍他米松治疗及出生体重均无显著差异。
- 6小时结果在168至475 mg范围时,建议完成24小时尿蛋白采集。
核心结论
- 基于6小时尿蛋白采集管理疑似子痫前期妊娠可行,且与24小时采集相比 maternal 和新生儿结局相似。
研究设计与样本
- 随机双盲对照预试验,2019年1月至2021年1月在一家三级大学医院开展,115例参与者中101例完成随访分析(6小时组51例,24小时组50例),样本量按概念验证设计经验性设定。
主要发现
- 6小时组和24小时组复合不良 maternal 结局率分别为15.6%和12.0%(P=.59)。
- 两组在新生儿不良结局率、剖宫产率、引产率、分娩孕周、倍他米松治疗及新生儿出生体重方面均无显著差异。
- 6小时组有7例因结果不一致而揭盲,其初始6小时结果范围为168至475 mg。
关键数值与推荐
- 传统子痫前期诊断需血压升高及24小时尿蛋白采集证实蛋白尿。
- 当6小时尿蛋白结果在168至475 mg范围时,建议完成24小时尿蛋白采集。
临床怎么用
- 对于疑似子痫前期住院孕妇,可考虑采用6小时尿蛋白采集替代24小时采集以缩短诊断时间并减少不便。
- 若6小时尿蛋白结果处于168至475 mg范围,应继续完成24小时尿蛋白采集以确认诊断。
局限性
- 本研究为预试验,样本量按概念验证设计经验性设定,可能不足以检测结局差异。
- 研究仅在单家三级大学医院开展,结果外推需谨慎。
- 6小时组有7例因结果不一致而揭盲,可能引入偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traditionally, the diagnosis of preeclampsia requires elevated blood pressure measurements and proteinuria demonstrated in a 24-hour urine collection. This prolonged urine collection is associated with patient discomfort, a delay in diagnosis, and in some cases, hospitalization for further management of outcomes. OBJECTIVE: We aimed to assess the feasibility, reliability, and association between maternal and neonatal outcomes of pregnancies managed according to a 6-hour vs 24-hour urine protein collection for suspected preeclampsia. STUDY DESIGN: This was a randomized controlled trial conducted at a tertiary university hospital between January 2019 and January 2021 (ClinicalTrials.gov Identifier: NCT03724786). Patients who were hospitalized for preeclampsia workup were asked to participate and randomized at a 1:1 ratio to 6- and 24-hour urine protein collection groups. Both groups collected urine for 24 hours, during which the collection was also tested after 6-hours. After 24 hours, both results were reviewed by one of the research staff, and either the 6- or 24-hour collection result was reported to the patient's managing physician and was documented in the patient's medical record. Both patient and the managing physician were blinded to group allocation. Unblinding was undertaken in cases of a discrepancy between the results (1 of 2 results of >300 mg protein), and the results were analyzed by intention to treat. The primary study outcome was defined as a composite of adverse maternal outcomes. The sample size was set empirically as per proof on concept design. RESULTS: During the study period, 115 patients participated in the trial, 101 of whom completed the follow-up and were analyzed-51 in the 6-hour group and 50 in the 24-hour group. Patient demographics were similar between the study groups. Unblinding occurred in 7 cases in the 6-hour group, in which the initial 6-hour result ranged from 168 to 475 mg. The rates of composite adverse maternal outcomes were 15.6% and 12.0% in the 6- and 24-hour groups, respectively (P=.59). No significant difference was demonstrated in the rate of adverse neonatal outcomes, cesarean delivery, induction of labor, gestational age at delivery, betamethasone treatment, or neonatal birthweight. CONCLUSION: Managing pregnancies suspected of preeclampsia with a 6-hour urine protein collection is feasible and associated with similar maternal and neonatal outcomes. In cases where the 6-hour result is in the 168 to 475 mg range, we propose completing a 24-hour collection.
引用
- Herman HG, Barda G, Miremberg H, et al. Management of pregnancies with suspected preeclampsia based on 6-hour vs 24-hour urine protein collection-a randomized double-blind controlled pilot trial. Am J Obstet Gynecol MFM. 2021. PMID: 34182189. doi:10.1016/j.ajogmf.2021.100429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。